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Actin oligomers hit the assembly line
A
ctin fi   lament production is a 
“green” industry. New fi  laments 
are assembled from a renewable 
pool of actin monomers, recycled from 
older, depolymerizing fi  laments. Okreglak 
and Drubin now reveal that old fi  laments 
aren’t always completely broken down—
short fragments generated by the severing 
protein cofi  lin are reused directly to con-
struct new actin structures (1).
Voytek Okreglak and David Drubin, 
from the University of California, Berkeley, 
study actin dynamics at sites of endocytosis 
in budding yeast. “Endocytosis culminates 
in a predictable burst of actin polymer-
ization followed by rapid disassembly, so 
we can watch and analyze the process at the 
cell cortex,” Drubin explains. To make these 
dynamics easier to see, the researchers often 
use mutant yeast that grow particularly large 
actin tails at their endocytic sites. In these 
enlarged tails, actin subunits are added at 
the end nearest the plasma membrane and 
removed at the opposite end, leading to a 
measurable fl  ux of actin toward the cell 
interior. “It’s similar to the leading edge of a 
migrating fi  broblast,” says Drubin.
In 2007, Okreglak and Drubin used this 
system to study the fi  lament-severing pro-
tein cofi  lin’s contribution to actin turnover in 
endocytosis (2). Okreglak followed this up 
by examining Aip1, a pro-
tein that works with cofi  lin 
to disassemble actin fi  la-
ments in vitro (3). To his sur-
prise, deleting Aip1 had no 
effect on disassembly rates 
in vivo, but in the course of 
his studies Okreglak noticed 
something even odder: actin 
fi  laments continued to as-
semble at endocytic sites in 
the presence of high concen-
trations of latrunculin A (lat A), a drug that 
inhibits polymerization by sequestering 
actin monomers. This lat A–resistant assem-
bly also occurred in wild-type cells, but was 
more pronounced in yeast lacking Aip1. 
“This was totally unexpected,” says Drubin. 
“It meant that there was some property of 
actin that we didn’t understand.”
One possibility was that these actin 
fi  laments evaded lat A inhibition by directly 
incorporating short actin oligomers instead 
of monomers. This mode of assembly has 
been seen in vitro (4, 5) but it wasn’t thought 
to occur in living cells—actin assembly is 
a highly controlled process, and it’s not 
clear how oligomers would be regulated. 
“Also,” adds Drubin, “we assumed that 
actin disassembly always went to comple-
tion, so that there wouldn’t 
be a pool of actin oligomers 
available in vivo.”
If lat A–resistant actin 
polymerization is mediated 
by oligomer assembly, why 
is the process enhanced in 
cells lacking Aip1? The re-
searchers wondered whether 
Aip1 regulates the balance 
between actin oligomers and 
monomers. The protein’s 
function in actin disassembly could be to 
generate monomers from the oligomeric 
fragments produced by cofi  lin. In Aip1’s 
absence, the fragments wouldn’t be dis-
mantled, and would be more available for 
lat A–resistant fi  lament assembly.
To test this idea, Okreglak and 
Drubin examined how Aip1 affected the 
oligomeric state of actin. In vitro, Aip1 
increased the amount of monomeric actin 
produced when actin fi  laments were bro-
ken down by cofi  lin. In yeast cells lacking 
Aip1, on the other hand, the amount of 
actin monomer was reduced by 45%.
Thus, Aip1 renews the actin monomer 
pool during fi  lament disassembly, but this 
regeneration isn’t necessary because short 
actin oligomers can be used to build new 
fi  laments instead. “Oligomers have really 
been overlooked,” says Drubin. “But they 
clearly contribute to actin assembly at 
endocytic sites, even in wild-type cells.”
Drubin now plans to investigate how 
Aip1 separates oligomeric fragments into 
monomers, and to determine how oligom-
ers are incorporated into growing fi  laments 
at endocytic sites. “No one had detected 
this pathway before,” says Drubin. “Now 
people have to look to see if it’s involved 
in other actin assembly processes too.”
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David Drubin and Voytek Okreglak (holding his son, Simon) discover that actin ﬁ  laments can 
assemble through the direct annealing of short actin fragments, rather than relying exclusively 
on the addition of monomers. The pathway is revealed by the continued assembly of actin (red) 
at sites of endocytosis (green) in the presence of latrunculin A (bottom), a drug that inhibits 
the polymerization of actin monomers. The process is particularly evident in budding yeast 
lacking the protein Aip1 (pictured), which, the researchers show, converts the actin oligomers 
produced by the ﬁ  lament-severing protein coﬁ  lin into latrunculin A–sensitive monomers.
“Oligomers 
have been 
overlooked, 
but they clearly 
contribute 
to actin 
assembly.”
Study identifies a new way for actin filaments to polymerize in vivo.
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